POOLED SAFETY ANALYSIS OF TEN CLINICAL STUDIES EVALUATING FIXED-DOSE ORAL TESTOSTERONE UNDECANOATE IN MALE PATIENTS WITH TESTOSTERONE DEFICIENCY

被引:0
|
作者
Khera, M. [1 ]
Miner, M. [2 ]
Goldstein, I. [3 ]
Goldstein, R. [4 ]
Chidambaram, N. [5 ]
Delconte, A. [5 ]
Dobs, A. [6 ]
机构
[1] Baylor Coll Med, Houston, TX USA
[2] Brown Univ, Providence, RI USA
[3] Univ Calif San Diego, San Diego, CA USA
[4] Halozyme, San Diego, CA USA
[5] Lipocine Inc, Salt Lake City, UT USA
[6] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
393
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Safety of a New SEDDS Formulation of Oral Testosterone Undecanoate (TU) in Hypogonadal Men: Data from Two Phase 3 Trials with Different Dose-Titration Algorithms
    Swerdloff, Ronald S.
    Salameh, Wael A.
    Dobs, Adrian S.
    Faulkner, Sandra M.
    Dudley, Robert E.
    Flippo, Gregory M.
    Kaminetsky, Jed C.
    Amory, John K.
    Danoff, Theodore M.
    Wang, Christina
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [32] DOSE-RESPONSE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY IN PATIENTS WITH FEMALE TO MALE GENDER IDENTITY DISORDER
    Sugimoto, Morito
    Ishii, Kazushi
    Kurahashi, Hiroaki
    Matumoto, Yuko
    Sako, Tomoko
    Nakamura, Aya
    Watanabe, Masami
    Nasu, Yasutomo
    Kumon, Hiromi
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 236 - 236
  • [33] Cost utility analysis of fixed-dose and free-dose combinations of oral medications in type 2 diabetes patients
    Vaidya, Varun
    Anupindi, Vamshi Ruthwik
    Pinto, Sharrel
    Kaun, Megan
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2016, 7 (03) : 181 - 187
  • [34] Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder
    Nakamura, Aya
    Watanabe, Masami
    Sugimoto, Morito
    Sako, Tomoko
    Mahmood, Sabina
    Kaku, Haruki
    Nasu, Yasutomo
    Ishii, Kazushi
    Nagai, Atsushi
    Kumon, Hiromi
    ENDOCRINE JOURNAL, 2013, 60 (03) : 275 - 281
  • [35] SAFETY OF A NEW SEDDS FORMULATION OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN: DATA FROM TWO PHASE 3 TRIALS WITH DIFFERENT DOSE-TITRATION ALGORITHMS
    Swerdloff, R. S.
    Sulameh, W.
    Dohs, A.
    Faulknel, S.
    Dudley, R.
    Flippo, G.
    Kaminetsky, J.
    Armory, J.
    Honig, S. H.
    Danoff, T.
    Wang, C.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 150 - 150
  • [36] The efficacy and safety of tiotropium/olodaterol fixed-dose combination in Chinese patients with chronic obstructive pulmonary disease:a pooled subgroup analysis of TONADO 1+2
    白春学
    China Medical Abstracts(Internal Medicine), 2020, 37 (01) : 44 - 44
  • [37] Overall And Cardiovascular Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination (fdc) In COPD: Pooled Analyses Of Four Phase Iii Studies
    Donohue, J. F.
    D'Urzo, A. D.
    Korn, S.
    Shrestha, P.
    Lei, A.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [38] Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease
    Raffaele, R
    Vecchio, I
    Giammusso, B
    Morgia, G
    Brunetto, MB
    Rampello, L
    EUROPEAN UROLOGY, 2002, 41 (04) : 382 - 386
  • [39] Efficacy and safety of fixed-dose combination brinzolamide 1%/brimonidine 0.2% as adjunctive therapy to prostaglandin analogs in patients with elevated intraocular pressure: Results from pooled analysis of two multicenter, randomized studies
    Hubatsch, Doug
    Realini, Tony
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [40] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Initial Disease Severity
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191